Programmed cell death ligand 1 (PD-L1) suppresses T-cell proliferation by interacting with programmed cell death protein 1 (PD-1) on T-cell membranes, hence decreasing the body’s anti-tumor immune response (Zhou et al., 2024). This evidence concerns the gene PDCD1 and neoplasm.